Skip to main content

Extraction socket grafting using recombinant human bone morphogenetic protein-2-clinical implications and histological observations

Abstract

Objectives

Rehabilitation of edentulous ridges to promote the insertion of dental implants has been the key indicator for retaining osseous structures since tooth extraction. Recombinant Bone Morphogenetic Protein-2(rhBMP-2) is exploited for bone augmentation due to its osteoinductive capacity. The objective of the study to determine the effectiveness of bone induction for implant placement by rhBMP-2 delivered on beta-tricalcium phosphate graft (β-TCP) and PRF following tooth extraction.

Results

Minimal changes in the width of the crestal bone relative to baseline values were found three months after socket grafting. A bone loss in the mesiodistal and buccolingual aspects of 0.6 ± 0.13 mm and 0.5 ± 0.13 mm was found, respectively. While drilling before the implant placement, the bone's clinical hardness evaluated through tactile was analogous to drilling into spruce or white pine wood. Total radiographic bone filling was seen in 3 months and no additional augmentation was needed during implant placement. Besides, histology shows no residual graft of bone particles. Therefore, the data from this study demonstrated that the novel combination of rhBMP-2 + β-TCP mixed with PRF has an effect on de novo bone formation and can be recommended for socket grafting before implant placement.

Introduction

Endosseous implants have currently been the therapy option for the treatment of an edentulous site [1,2,3]. However, after extraction, owing to osteoclastic activity, the alveolar process undergoes resorption, leading to reduced alveolar ridge measurements in both the vertical and horizontal planes [4]. Alveolar ridge alterations ranging from 40–60% tend to occur as early as three months after extraction [5]. The altered height and width have practical and aesthetic issues that result in impaired recovery. Within 12 months after removal of the tooth, non-grafted edentulous sites can lose up to fifty percent of ridge width [6]. An average reduction reported in the width and height of grafted edentulous site`s is minimal compared to non-grafted site`s, with most cases requiring no additional augmentation to have the implants placed [7]. Therefore, surgical approaches aiming to maintain ridge volume by preservation before implant placement are deemed useful. Platelet-rich fibrin (PRF) comprises of fibrin matrix enriched with platelets and growth factors. Hence it is a powerful bioscaffold for tissue regeneration [8]. Alloplastic materials like tri-calcium phosphate (TCP) are viable substitutes for autogenous bones or other bone substitutes [9]. When blended with bone substitutes, the ability of PRF for regeneration is enhanced. The Recombinant human bone morphogenetic protein-2 (rhBMP-2) is promising in various bone augmentation procedures [10]. An animal study has reported unique bone formation escorted with rhBMP-2 impregnated β-TCP scaffold in the cranial bone defect model [11]. The utility of rhBMP-2 and Acellular Collagen Sponge (ACS) in extraction defects helps to reconstruct the buccal plate. The alveolar ridge dimensions are crucial for implant placement, and rhBMP-2 aids in maintaining ridge configuration favoring implant placement [12]. Similarly, the crucial bone structure inherent in the healing socket is also important. Clinically, radiographically and histologically, the efficacy of ridge preservation using rh-BMP-2 in conjunction with β-TCP and PRF was therefore evaluated.

Main text

Materials and method

Following informed consent, two systemically healthy patients (M:F1:1, aged 23 years and 30 years, respectively) who required the extraction of teeth for reasons other than periodontitis were recruited (Additional file 1: Fig S1, Additional file 2: Fig S2). Initial treatment, consisting of oral hygiene instructions, supragingival and subgingival scaling, was done after careful assessment and diagnosis. The full mouth plaque index (FMPI, [13]) and Full mouth papillary bleeding index (FMPBI) scores were low at the baseline and remained low (< 1) during the treatment period (Table 1) [14]. We included two patients with four sites. This was accompanied by a clinical and radiographic analysis of the chosen areas (Table 2).

Table 1 Full Mouth Papillary Bleeding Index (FMPBI) and Full Mouth Plaque Index (FMPI)
Table 2 Measurements at ridge prior tooth/root piece extraction (at baseline) and at 3 months (Post-operative)

Surgical procedure

A pre-surgical rinse with chlorhexidine gluconate 0.12% mouthwash (Rexidine®, Indoco Remedies Ltd) for 2 min was advocated. After administering local anesthesia (Xicaine®, ICPA Health Products Limited), flapless minimally invasive periotomy was carried out with a Bard-Parker Surgical blade number #15 (Glassvan®, Niraj Industries Pvt Ltd) to facilitate atraumatic extraction without causing damage to the buccal plate (Additional file 3: Fig S3). The walls of the socket were consecutively tested for integrity. Twenty milliliters of venous blood is removed from the antecubital vein in two test tubes. Centrifugation of the blood was carried out at 3000 rpm for 12 min to obtain PRF. [15] One part of PRF was mixed with β-TCP (OSTEON TM II Genoss Co., Ltd, Korea) and 1.5 mg/mL concentration of rhBMP-2 (GibcoR, Recombinant Human Bone Morphogenetic protein-2, Life Technologies, Van Allen Way, Carlsbad, California,16) to enhance wound healing. The socket was filled up to the level of the alveolar crest. The remaining clot was compressed to a membrane of high tensile strength. The membrane was then carefully placed, covering the graft material. The approximation of the surgical site was made using a 3–0 silk suture. (Centisilk Non-Absorbable Surgical Suture USP) (Additional file 4: Fig S4).

The patients were checked for implant placement after three months (Additional file 5: Fig S5). Following administration of local anesthesia (Xicaine®, ICPA Health Products Limited), an incision was given from the line angle of adjacent teeth to elevate the mucoperiosteal flap and expose the underlying bone (Additional file 6: Fig S6). Alveolar ridge measurements were taken intrasurgically and were compared with the pre-operative alveolar dimensions (Table 2). A 2 mm trephine drill was initially used to harvest bone core for histological examination. The bone tissue was moved to a mixture containing 10% neutral buffered formalin. A decalcification protocol was used to remove the bone mineral component to ease the fine section and better study of new bone-forming cells. The tissues were stained with Hematoxylin & Eosin (H & E, Fig. 1, [17]).

Fig. 1
figure1

Histological view of new bone formation 3 months after ridge preservation

Sequential drills were used for osteotomy preparation, based on the size of the implant selected. An implant (Equinox, Myriad Plus TM implant system) of the largest possible dimension was placed according to the manufacturer's recommendations, and further follow-up was carried out. Four implants were placed in two patients (Additional file 7: Fig S7, Additional file 8: Fig S8).

Statistical analysis

The Wilcoxon sign ranked test was used to compare the means of the parameters used before and after socket grafting. A p < 0.05 was considered to be statistically significant. [18].

Discussion

For peri-implant soft tissues, the healthy osseous contour creates a skeleton. Atraumatic extraction helps to eliminate bone resorption and preserve the dimensions of the alveolar ridge during healing. In the present study, three months following socket preservation, minimal changes in the alveolar ridge dimensions were seen (mesiodistal bone loss 0.6 ± 0.13 mm, and buccolingual bone loss 0.5 ± 1.13 mm), and the results were not significant. The physiological hardness of the bone measured before implant insertion during drilling produced a tactile feeling similar to drilling into spruce or white pine wood in all four positions [19]. Although bone density evaluation using Hounsfield units was not done, dense to the thick porous cortical bone on the crest and coarse trabecular bone underneath was seen on radiographic examination, suggesting D2 bone quality [20]. Histologically, the presence of essential mineralized osteoid trabeculae and spindle nuclear cell soft tissue revealed new bone structure. All four implants achieved good primary stability. As soft tissue grows six times faster than the bone tissue [21], in the present study, a saddle of PRF membrane covering the socket helps prevent the gingival connective tissue down-growth. It also held the osseous graft in place [22]. Additionally, the membrane also aided in clot stabilization. PRF principally contains a fibrin matrix rich in platelets and leukocytes. Cytokines such as IL-1β, -4, and -6, and growth factors such as PDGF, TGF-beta, IGF, EGF, and VEGF are other vital components present. These are the critical elements in bone regeneration [23]. Fibrin gel in coagulation cascade aids in fibrinogen molecules collaboration and formation of a highly biocompatible three-dimensional fiber network [24]. PRF has also contributed to accelerated wound healing and increased bone graft density and maturation [19]. β-TCP is (purified, microcrystalline porous) a form of calcium phosphate. Remarkable resorption of β-TCP particulate is estimated at around 3 to 6 months after placement. In addition, particles are well absorbed into the current formation of bones, forming a thick cancellous matrix. Biodegradation of graft takes place both by osteoclastic activity as well as chemical dissolution by tissue fluids. A solid new bone formation was evident during implant placement, which favored the placement of ideal implant size. The use of rhBMP-2 necessitates the use of a carrier for its osteoinductivity [25]. Misch emphasized the advantages of rhBMP-2 in new bone growth in patients requiring extraction. In the present study, rhBMP-2 was used as an agent to promote socket repair and aid in ridge augmentation when combined with a part of β -TCP. Fiorellini et al. [16] in their study showed significantly greater bone augmentation with 1.50 mg/mL/rhBMP-2 compared to a concentration of 0.75 mg/mL in socket defects. Therefore, in the present study, a concentration of 1.50 mg/mL/rhBMP-2 was used. Various studies [26, 27] have supported using a mixture of β-TCP and rh-BMP-2 to facilitate the increased bone formation; hence rh-BMP-2 was used in combination with β-TCP to promote bone growth.

Limitations

The present analysis explains in a small sample the findings obtained. Although there is evidence of good-quality bone formation during a short period following the use of a combination of rhBMP-2, β-TCP, and PRF, more extensive population studies may further improve the significance of the results obtained. PRF was used to cover and hold the graft in place. The increase in keratinized tissue thickness following the PRF membrane placement was not evaluated. In addition, follow-up outcomes have been recorded for just six months (Additional file 9: Fig S9); additional long-term patient monitoring will be helpful. Even though pre-operative CBCT was taken but due to the patient's cost concerns and unwillingness, the post-operative CBCT could not be accepted.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

rhBMP:

2-recombinant bone morphogenetic protein

β-TCP:

Beta-tricalcium phosphate

PRF:

Platelet rich fibrin

PDGF:

Platelet-derived growth factor

TGF:

Beta transforming growth factors

IGF:

The insulin-like growth factor

EGF:

Epithelial growth factor

VEGF:

Vascular endothelial growth factor

FMPBI:

Full Mouth Papillary Bleeding Index

FMPI:

Full Mouth Plaque Index

MB:

Mesio-buccal root

DB:

Disto-buccal root

RBH:

Residual bone height-measured from alveolar crest to anatomical structure

M-D:

Mesiodistal width

B-L:

Buccolingual width

References

  1. 1.

    Berglundh T, Persson L, Klinge B. A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years. J Clin Periodontol. 2002;29(Suppl. 3):197–212.

    Article  Google Scholar 

  2. 2.

    Busei D, Dula K, Belser UC, Hirt HP, Berthold H. Localized ridge augmentation using guided bone regeneration. II. Surgical procedure in the mandible. Int J Periodontics Restorative Dent. 1995;15(1):10–29.

    Google Scholar 

  3. 3.

    Adell R, Lekholm U, Brånemark PI, Lindhe J, Rockler B, Eriksson B, Lindvall AM, Yoneyama T, Sbordone L. Marginal tissue reactions at osseointegrated titanium fixtures. Swed Dent J Suppl. 1985;28:175–81.

    CAS  PubMed  Google Scholar 

  4. 4.

    Pietrokovski J, Massler M. Alveolar ridge resorption following tooth extraction. J Prosthet Dent. 1967;17(1):21–7.

    CAS  Article  Google Scholar 

  5. 5.

    Schropp L, Wenzel A, Kostopoulos L, Karring T. Bone healing and soft tissue contour changes following single-tooth extraction: a clinical and radiographic 12-month prospective study. Int J Periodont Rest. 2003;1:23–4.

    Google Scholar 

  6. 6.

    Araújo M, Linder E, Wennström J, Lindhe J. The influence of bio-oss collagen on healing of an extraction socket: an experimental study in the dog. Int J Periodont Rest. 2008;28(2):123–35.

    Google Scholar 

  7. 7.

    Barone A, Ricci M, Tonelli P, Santini S, Covani U. Tissue changes of extraction sockets in humans: a comparison of spontaneous healing vs ridge preservation with secondary soft tissue healing. Clin Oral Implants Res. 2013;24(11):1231–7.

    PubMed  Google Scholar 

  8. 8.

    Kang YH, Jeon SH, Park JY, Chung JH, Choung YH, Choung HW, Kim ES, Choung PH. Platelet-rich fibrin is a Bioscaffold and reservoir of growth factors for tissue regeneration. Tissue Eng A. 2010. https://doi.org/10.1089/ten.tea.2010.0327.

    Article  Google Scholar 

  9. 9.

    Bhatt AK, Pandey VA. Alveolar Ridge Preservation with beta-tricalcium phosphate bone graft and implant placement: a case report. IJSS Case Rep Rev. 2015;1:28–31.

    Google Scholar 

  10. 10.

    Ramly EP, Alfonso AR, Kantar RS, Wang MM, Siso JR, Ibrahim A, Coelho PG, Flores RL. Safety and efficacy of recombinant human bone morphogenetic protein-2 (rhBMP-2) in craniofacial surgery. Plast Reconstr Surg Glob Open. 2019. https://doi.org/10.1097/GOX.0000000000002347.

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Lim HP, Mercado-Pagan AE, Yun KD, Kang SS, Choi TH, Bishop J, Koh JT, Maloney W, Lee KM, Yang YP, Park SW. The effect of rhBMP-2 and PRP delivery by biodegradable β-tricalcium phosphate scaffolds on new bone formation in a non-through rabbit cranial defect model. J Mater Sci. 2013;24(8):1895–903.

    CAS  Google Scholar 

  12. 12.

    Coomes AM, Mealey BL, Huynh-Ba G, Barboza-Arguello C, Moore WS, Cochran DL. Buccal bone formation after flapless extraction: a randomized, controlled clinical trial comparing recombinant human bone morphogenetic protein 2/absorbable collagen carrier and collagen sponge alone. J Periodontol. 2014;85(4):525–35.

    CAS  Article  Google Scholar 

  13. 13.

    Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of victamine C. J Periodontol. 1970;41(1):41–3.

    CAS  Article  Google Scholar 

  14. 14.

    Mühlemann HR. Psychological and chemical mediators of gingival health. J Prev Dent. 1977;4(4):6–17.

    PubMed  Google Scholar 

  15. 15.

    Choukroun J, Adda F, Schoeffer C, Vervelle A. PRF: an opportunity in perio-implantology. Implantodontie. 2000;42:55–62.

    Google Scholar 

  16. 16.

    Fiorellini JP, Howell TH, Cochran D, Malmquist J, Lilly LC, Spagnoli D, Toljanic J, Jones A, Nevins M. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol. 2005;76(4):605–13.

    CAS  Article  Google Scholar 

  17. 17.

    Valentine G, Piper K. Preparation of mineralized tissue for light microscopy. In : Forensic microscopy for skeletal tissues .Humana Press, Totowa; 2012. p. 37--50.

  18. 18.

    Wilcoxon F. Individual comparisons of grouped data by ranking methods. J Econ Entomol. 1946;39(2):269–70.

    CAS  Article  Google Scholar 

  19. 19.

    Misch CE. The implant quality scale: a clinical assessment of the health–disease continuum. Oral Health. 1998;88(7):15–20.

    CAS  PubMed  Google Scholar 

  20. 20.

    Misch CE. Bone character: second vital implant criterion. Dent today. 1988;7(5):39–40.

    Google Scholar 

  21. 21.

    Wikesjö UM, Selvig KA, Zimmerman G, Nilvéus R. Periodontal repair in dogs: healing in experimentally created chronic periodontal defects. J Periodontol. 1991;62(4):258–63.

    Article  Google Scholar 

  22. 22.

    Dahlin C, Linde A, Gottlow J, Nyman S. Healing of bone defects by guided tissue regeneration. Plast Reconstr Surg. 1988;81(5):672–6.

    CAS  Article  Google Scholar 

  23. 23.

    Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Sur Oral Med Oral Pathol Oral Radiol Endodontol. 2006;101(3):e45-50.

    Article  Google Scholar 

  24. 24.

    Bensaıd W, Triffitt JT, Blanchat C, Oudina K, Sedel L, Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials. 2003;24(14):2497–502.

    Article  Google Scholar 

  25. 25.

    Maus U, Andereya S, Gravius S, Ohnsorge JA, Niedhart C, Siebert CH. BMP-2 incorporated in a tricalcium phosphate bone substitute enhances bone remodeling in sheep. J Biomater Appl. 2008;22(6):559–76.

    CAS  Article  Google Scholar 

  26. 26.

    Ohyama T, Kubo Y, Iwata H, Taki W. BETA-Tricalcium Phosphate Combined With Recombinant Human Bone Morphogenetic Protein-2: a substitute for autograft, used for packing interbody fusion cages in the canine lumbar spine. Neurol Med Chir. 2004;44(5):234–41.

    Article  Google Scholar 

  27. 27.

    Hoshino M, Egi T, Terai H, Namikawa T, Takaoka K. Repair of long intercalated rib defects using porous beta-tricalcium phosphate cylinders containing recombinant human bone morphogenetic protein-2 in dogs. Biomaterials. 2006;27(28):4934–40.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Affiliations

Authors

Contributions

Primary author KJD performed the surgical procedures and drafted the manuscript. Second author VSB conducted the examinations and reviewed the manuscript. The third author SBS, reviewed & revised the manuscript. The fourth author PVD changed the final writing of the document. Fifth author GCR assisted in all surgical procedures and helped in drafting the manuscript through a literature search. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Khushboo Jeevan Durge.

Ethics declarations

Ethics approval and consent to participate

The study protocol Number- DMIMS(DU)/IEC/2016-17-5080 was first approved by the Ethical Committee of Datta Meghe Institute of Medical Sciences, Sawangi (Meghe), Wardha, Maharashtra, India, and written informed consent was obtained from all the patients.

Consent for publication

Written consent for publication taken.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Fig S1.

Pre-Operative Clinical view.

Additional file 2: Fig S2.

Pre-operative Radiographic view.

Additional file 3: Fig S3.

Extracted root piece and tooth.

Additional file 4: Fig S4.

Approximation after Ridge/socket preservation.

Additional file 5: Fig S5.

Clinical view of edentulous site 3 months after ridge preservation.

Additional file 6: Fig S6.

Clinical view after mucoperiosteal flap reflection.

Additional file 7: Fig S7.

Implants in position.

Additional file 8: Fig S8.

After final prosthesis placement.

Additional file 9: Fig S9.

Radiograph showing implant in position at six months follow up.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Durge, K.J., Baliga, V.S., Sridhar, S.B. et al. Extraction socket grafting using recombinant human bone morphogenetic protein-2-clinical implications and histological observations. BMC Res Notes 14, 61 (2021). https://doi.org/10.1186/s13104-021-05476-0

Download citation